N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis

Sponsor: Global Stem Cell Center, Baghdad • ClinicalTrials.gov ID: NCT07374185

Registry updated: 2026-09-15
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

the study includes patients with liver cirrhosis irrespective of the stage excluding people with active tumor or other major health issue endangering life, the protocol includes the use of autologous bone marrow derived mononuclear cells harvested from the same patient under local anesthesia ,followed by cell concentration and viability testing , then final product is combined with small volume of 2 cc of Wharton gel exosomes 20 billion per to be administered intravenously.

Interventions

  • Autologous Bone Marrow Aspirate Concentrate (Procedure)
    using autologous bone marrow aspirated from iliac crest ,centrifuged and then injected intravenously

Eligibility criteria

Inclusion Criteria: any patient with liver cirrhosis , less than 80 years of age - Exclusion Criteria: 1. active malignancy. 2. severe sepsis. 3. pregnancy. -

Conditions

Liver Cirrhosis

Locations

  • Capital Private Hospital Alrabee Street — Baghdad, Iraq, Iraq
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record